Radio-223 nel trattamento del carcinoma della prostata metastatico resistente alla castrazione (mCRPC): risultati di una valutazione di Health Technology Assessment

Translated title of the contribution: [Autom. eng. transl.] Radio-223 in the treatment of castration-resistant metastatic prostate cancer (mCRPC): results of a Health Technology Assessment assessment

Dario Sacchini, Flavia Kheiraoui, Carlo Favaretti, Anna Maria Ferriero, R. Danesi, G. De Vincentis, Silvia Fanti, G. Procopio, M. Tucci, U. Ricardi, D. Croce, U.

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of '[Autom. eng. transl.] Radio-223 in the treatment of castration-resistant metastatic prostate cancer (mCRPC): results of a Health Technology Assessment assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences